Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 25, 2013

FDA approves Bayer/Onyx, J&J and GSK drugs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Filings FDA approves Bayer/Onyx drug for late-stage differentiated thyroid cancer… read more FDA approves J&J’s Olysio as a treatment for chronic hepatitis C virus infection… read more FDA approves GSK’s pandemic flu vaccine for use in the event of an H5N1 bird flu epidemic… read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters